(Q48712442)

English

Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis

scientific article published on 20 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

colorectal cancer

1 reference

based on heuristic

inferred from title

author name string

Pei-Ching Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Jen-Kou Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Chun-Chi Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Huann-Sheng Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Shung-Haur Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Jeng-Kai Jiang

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Yuan-Tzu Lan

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Tzu-Chen Lin

8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Anna Fen-Yau Li

9

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Wei-Shone Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Shih-Ching Chang

11

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

publication date

20 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

International Journal of Colorectal Disease

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

27

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

10

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

1333-1338

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

Comparison of L-selectin and E-selectin ligand specificities: the L-selectin can bind the E-selectin ligands sialyl Le(x) and sialyl Le(a)

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

Are right- and left-sided colon neoplasms distinct tumors?

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

Microsatellite instability in cancer of the proximal colon

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

NCCN Clinical Practice Guidelines in Oncology: colon cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00384-012-1447-1

21 January 2018

Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA19-9 as a predictor of recurrence in patients with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00384-012-1447-1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22426691

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48712442&oldid=2209721469"